u/milos_vanhecke
Contributes reviews on supplier material. Based in Lagos.
member · joined 15 Jun 2025
Overview — page 2 of 3
comment on receptor: what the trials say vs what this community says in c/glp1science · 1 points · 4 months ago
do not extrapolate rodent data to human dosing without saying so
comment on help me understand purity, I have read the wiki twice in c/coa · 6 points · 4 months ago
area% is not mass%, and here is exactly why it matters
comment on small win: SURMOUNT stopped being a problem at week 65 in c/trialwatch · 57 points · 5 months ago
Not convinced. The evidence does not support that reading.
comment on genuine question about hazard ratio that I am slightly embarrassed to ask in c/trialwatch · 1 points · 6 months ago
phase 2 is not phase 3, smaller n and shorter trial
comment on [PSA] receptor is not what most of this community thinks it is in c/glp1science · 7 points · 8 months ago
the 15-day half-life means week 15 is still ramp-up pharmacokinetically
comment on week 56 check-in — 12kg down, injection-site soreness manageable, one thing confusing me in c/coa · 38 points · 9 months ago
axis labels included, always
comment on [Discussion] the related substances advice in here is 9 years out of date in c/coa · 13 points · 9 months ago
post the whole document, not the headline number
Adding to this: COA is doing more work than the comment implies.
comment on small win: hazard ratio stopped being a problem at week 51 in c/trialwatch · 10 points · 9 months ago
off-label use data is different from approved-indication data
comment on [Discussion] can we stop arguing about mechanism until somebody posts a number in c/glp1science · 79 points · 10 months ago
incretin physiology is gastric emptying, the mechanism layer
comment on small win: TRIUMPH stopped being a problem at week 45 in c/trialwatch · 37 points · 1 year ago
Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.
comment on appetite: the version I wish someone had shown me in week 1 in c/glp1science · 178 points · 1 year ago
glucagon-receptor contribution is incretin for dual and triple agonism
comment on appetite: the version I wish someone had shown me in week 1 in c/glp1science · 159 points · 1 year ago
cite the paper: journal, year, first author, links optional
comment on [Results] 96 weeks on 12.5mg, full numbers, ask me anything boring in c/coa · 20 points · 1 year ago
Batch number and date of analysis? Both are load-bearing.
comment on three years of certificate of analysis threads, summarised so you do not have to read them in c/coa · 355 points · 1 year ago
PDF metadata is checkable in fifteen seconds
comment on related substances is the most under-discussed thing in c/scamalerts in c/coa · 2 points · 1 year ago
Water content on the document? That affects your concentration math.
comment on the SELECT thing finally clicked for me and I want to write it down in c/trialwatch · 277 points · 1 year ago
Not to be pedantic but TRIUMPH and SURPASS are being used interchangeably and they are not interchangeable in real life.
comment on stalled for 23 weeks at 5mg and I refuse to panic this time in c/coa · 52 points · 1 year ago
Water content on the document? That affects your concentration math.
comment on am I the only one who found SELECT harder than the injections in c/trialwatch · 536 points · 1 year ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on [Results] 96 weeks on 5mg, full numbers, ask me anything boring in c/coa · -33 points · 1 year ago
Metadata check caught a COA that was created in a browser four months after the analysis date. Not evidence of fraud, but worth flagging to JEEP.
comment on the FLOW question that gets asked weekly, answered properly in c/trialwatch · 4 points · 1 year ago
phase 2 is not phase 3, smaller n and shorter trial